- In October 2024, Bruker Corporation unveiled the creation of a new division, Bruker Spatial Biology, which will provide a wide range of comprehensive solutions for spatial biology. The division aims to advance biomedical research by offering a suite of spatial biology instruments, assays, software, data analytics, and contract research organization (CRO) services, focusing on the industry's most promising technologies
- In April 2024, Vizgen, Inc. introduced the MERSCOPE Ultra Platform and MERFISH 2.0 chemistry at the AACR 2024 Annual Meeting. These advanced tools are specifically designed to support both basic and translational research. The MERSCOPE Ultra offers an optimal combination of imaging area and throughput, making it a cutting-edge platform for spatial transcriptomics imaging
- In May 2023, Bio-Techne unveiled an expansion of its Advanced Cell Diagnostics (ACD)-branded RNAscope in situ hybridization (ISH) portfolio with the introduction of a multi-omic workflow for the Standard BioTools Hyperion Imaging System. The new RNAscope HiPlex12 Flex Kit allows for the visualization of highly multiplexed RNA biomarkers using the Hyperion XTi or earlier versions of the Hyperion Imaging System
- In November 2021, Illumina, Inc. and Genetic Alliance launched the iHope Genetic Health program, designed to provide whole-genome sequencing (WGS) to tens of thousands of patients worldwide affected by genetic diseases. Through this initiative, Illumina will support Genetic Alliance, a global nonprofit dedicated to advancing genetics for human health, in establishing networks of clinics and laboratories equipped with cutting-edge genomic technology to deliver precision diagnoses for patients with rare genetic conditions
- In August 2020, Horizon Discovery Group plc expanded its CRISPR screening services portfolio by adding single-cell RNA sequencing-linked pooled CRISPR screening. This new platform provides high-quality screening data and valuable biological insights to help address key challenges in target identification and validation
